The presence or absence of oestrogen receptor protein in human breast cancer is now well established as an index for predicting response to hormonal therapy and as an independent prognostic factor (Jensen, 1975; Hawkins et al., 1980) . Additional assessment of progesterone receptor activity has been reported to increase further the accuracy of selecting patients for hormonal therapy (Horrowitz et al., 1975; Knight et al., 1980) . More recently, studies of rat mammary tumours have shown that there seems to be an antagonistic action between oestrogen receptor activity and cyclic AMP binding proteins (subunits of the enzyme protein kinase) such that hormone-dependent tumours have high oestrogen receptor and low cyclic AMP-binding activities (Cho-Chung et al., 1978) . Preliminary studies indicate that this activity also may be of prognostic significance in human breast cancers (Miller et al., 1983) .
Breast cancers are heterogeneous in both morphology and function: they often show considerable variations in, for example, oestrogen receptor activity across the tumour (Braunsberg, 1975; Hawkins et al., 1977; Silfversward et al., 1980) (Miller et al. 1985; Hawkins et al., 1975; Hawkins et al., 1981) used previously, the assays for steroid receptors being slightly modified by the use of the buffer required for cyclic AMP binding assay (Miller et al., 1985) , a high speed supernatant and delayed addition of monothioglycerol. These changes did not influence the steroid receptor values. For each assay the data were analysed according to Scatchard (1949) .
The total soluble protein concentration in each cytosol was determined by the dye-binding method of Bradford (1976) , and the DNA content of the nuclear pellet was determined by a modification of the method of Burton (1956) .
In an essential preliminary investigation, the extent of variations due to the analytical method used, was determined by dividing a large tumour as finely as possible, mixing and redividing it into 5 portions for assay. The resulting intra-assay precisions are shown in Table I. For each of the 12 selected tumours, the P, C and M portions were examined histologically. There When the three portions from each of the 12 tumours were examined biochemically, the pellet DNA content and steroid receptor concentrations on a wet weight basis, were significantly lower in the C and M zones than in the periphery (Table II) . By contrast, soluble protein concentration and cyclic AMP binding activity did not significantly change from centre to periphery.
With a view to eliminating the effect of variations in tumour cellularity on the apparent changes in concentration of each binding protein, the relationships of cellularity to (a) soluble protein concentration (mg ml -1 cytosol) and (b) pellet DNA content (pg mg-1 tumour) were examined. The results showed that in each tumour zone, the estimates of tumour cellularity were strongly correlated with pellet DNA content (P< 0.001, P < 0.001, P < 0.05 for the C, M and P zones respectively, by linear regression analysis), but only weakly related to soluble protein concentration (P=NS, P<0.05, P=NS for the C, M and P zones respectively). DNA content is thus a good index of cellularity and expression of the three binding protein activities on this basis may be expected to eliminate the influence of cellularity. Even on this basis, significant variations in binding activity across the tumours remained (Figure 1) . While on average, the concentrations of the steroid receptor activities fell from periphery to centre, the reverse change was seen in cyclic AMP binding activity.
For the steroid receptor activities, these changes were apparent irrespective of the way in which concentrations were expressed (i.e. mg-1 wet weight, mg-1 protein or g-1 DNA): for cyclic AMP binding activity, the difference was only apparent on a DNA basis. To our knowledge, this is the first report of the simultaneous measurement of the concentrations of these three high affinity binding proteins across a tumour. Trans-tumoral variations in binding protein concentration might derive from at least 3 sources: variations in malignant epithelial cells/stroma ratio ('cellularity'), the existence of 2 or more cell populations, or variations in cell viability/function. In agreement with an earlier study (Mason et al., 1982) , DNA content of the tumour was found to be a good index of cellularity, yet even after expression of results on a DNA basis, significant trans-tumoural variations in the concentrations of binding protein remained. It is therefore unlikely that these variations are due to changes in cellularity. Differences in cell type across a tumour could explain the present findings. Although previous studies have demonstrated an inverse correlation between oestrogen receptor activity and lymphocytic infiltration (Rosen et al., 1975) or tumour macrophage content (Steele et al., 1986) between tumours, no obvious differences in lymphocytic infiltration were observed here. However, since macrophages are not easily distinguished from tumour cells in the breast (Steele et al., 1986) , the possibility remains that the proportion of each cell type varies across a large tumour.
In our view, it seems most likely that the transtumoural variations reside in differences in the viability/function of the malignant epithelial cell populations. Large tumours might be expected to be less well vascularised in the centre than at the periphery which could perhaps ultimately lead to central necrosis, but histologically there were no gross differences to provide evidence for such a chronic, non-specific effect on cell viability. It may be, however, that there are acute, more specific changes across a tumour. These may be similar to the rapid, inverse changes in cyclic AMP binding activity and oestrogen receptor concentration which occur during the regression of hormone-dependent mammary tumours in the rat (Cho-Chung et al., 1978) .
It is concluded that in a large breast cancer, since both cyclic AMP binding and oestrogen receptor activity are indices of hormonal sensitivity (Kvinnsland et al., 1983; Watson et al., 1986) , (1) it may be important to assay the entire tumour or sample all zones for the assessment of binding protein concentrations and (2) transtumoural variations in binding protein activity may be a reflection of differences in biological behaviour between the centre and periphery.
